Daiichi Sankyo (OTCMKTS:DSNKY) Issues FY 2024 Earnings Guidance

Daiichi Sankyo (OTCMKTS:DSNKY) updated its FY 2024 earnings guidance on Thursday. The company provided earnings per share guidance of 0.800-0.800 for the period. The company issued revenue guidance of $12.3 billion-$12.3 billion.

Daiichi Sankyo Trading Down 1.4 %

DSNKY traded down $0.44 during trading on Friday, reaching $32.13. The company had a trading volume of 55,627 shares, compared to its average volume of 114,101. The firm’s 50-day simple moving average is $35.04 and its 200 day simple moving average is $35.38. Daiichi Sankyo has a 12-month low of $25.26 and a 12-month high of $42.48.

Daiichi Sankyo Company Profile

Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.